Combination Treatment with Two Targeted Agents Shows Promise in Previously Treated CLL
What makes the British Society for Haematology (BSH) Annual Scientific Meeting unique?
A "chemo-sparing" MRD-driven strategy for CLL
Targeted treatments for AML: the revolution
Moving towards personalized therapy for AML